Abstract Purpose of Review As a chronic and relapsing disease, obesity impairs metabolism
and causes cardiovascular diseases. Although behavioral modification is important for the …

As a chronic and relapsing disease, obesity negatively impacts the health of men to a
greater extent than that of women, with a higher risk of cardiovascular disease. Since …

In the last 30 years, obesity has rapidly increased and obesity-related comorbidities have
surged. Once considered to be a problem only in developed nations, obesity has become a …

Obesity is among the leading causes of morbidity and mortality worldwide and its
prevalence continues to increase globally. Because obesity is a chronic, complex, and …

Obesity is one of the most serious and prevalent non-communicable diseases of the twenty-
first century. It is also a patient-centered condition in which affected individuals seek …

Obesity is a chronic disease with a continuously rising prevalence that currently affects more
than half a billion people worldwide. Energy balance and appetite are highly regulated via …

The management of obesity remains a major challenge. Dietary therapy often fails, whereas
bariatric surgery, although successful, is demanding and applicable to a limited number of …

Introduction: Obesity poses a significant increase in morbidity and mortality and thus five anti-
obesity drugs have been approved currently by US FDA. Several phase 3 trials have shown …

Recently, the recognition of obesity as a complex disease that requires chronic management
has become more widespread. There has also been a movement away from a focus on …

Objective: To synthesize the evidence from systematic reviews of clinical trials investigating
the effectiveness of pharmacological therapies approved by the Australian Therapeutic …